These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32350675)

  • 1. Role of long non-coding RNAs (LncRNAs) in multiple sclerosis: a brief review.
    Taghizadeh E; Taheri F; Samadian MM; Soudyab M; Abi A; Gheibi Hayat SM
    Neurol Sci; 2020 Sep; 41(9):2443-2451. PubMed ID: 32350675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Non-Coding RNAs, Novel Offenders or Guardians in Multiple Sclerosis: A Scoping Review.
    Jalaiei A; Asadi MR; Sabaie H; Dehghani H; Gharesouran J; Hussen BM; Taheri M; Ghafouri-Fard S; Rezazadeh M
    Front Immunol; 2021; 12():774002. PubMed ID: 34950142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of hub lncRNA ceRNAs in multiple sclerosis based on ceRNA mechanisms.
    Ding Y; Li T; Yan X; Cui M; Wang C; Wang S; Zhang F; Zhang R
    Mol Genet Genomics; 2021 Mar; 296(2):423-435. PubMed ID: 33507382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of lncRNAs in multiple sclerosis.
    Ghaderian S; Shomali N; Behravesh S; Danbaran GR; Hemmatzadeh M; Aslani S; Jadidi-Niaragh F; Hosseinzadeh R; Torkamandi S; Mohammadi H
    J Neuroimmunol; 2020 Oct; 347():577347. PubMed ID: 32745803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncoding RNAs in multiple sclerosis.
    Yang X; Wu Y; Zhang B; Ni B
    Clin Epigenetics; 2018 Nov; 10(1):149. PubMed ID: 30497529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Biomarker and Therapeutic LncRNAs in Multiple Sclerosis Through Targeting Memory B Cells.
    Ghoveud E; Teimuri S; Vatandoost J; Hosseini A; Ghaedi K; Etemadifar M; Nasr Esfahani MH; Megraw TL
    Neuromolecular Med; 2020 Mar; 22(1):111-120. PubMed ID: 31576494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide identification and analysis of the eQTL lncRNAs in multiple sclerosis based on RNA-seq data.
    Han Z; Xue W; Tao L; Lou Y; Qiu Y; Zhu F
    Brief Bioinform; 2020 May; 21(3):1023-1037. PubMed ID: 31323688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of non-coding RNAs in neuroinflammatory process in multiple sclerosis.
    Nowak A; Wicik Z; Wolska M; Shahzadi A; Szwed P; Jarosz-Popek J; Palatini J; Postula M; Czlonkowska A; Mirowska-Guzel D; Eyileten C
    Mol Neurobiol; 2022 Aug; 59(8):4651-4668. PubMed ID: 35589919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOTAIR but not ANRIL long non-coding RNA contributes to the pathogenesis of multiple sclerosis.
    Pahlevan Kakhki M; Nikravesh A; Shirvani Farsani Z; Sahraian MA; Behmanesh M
    Immunology; 2018 Apr; 153(4):479-487. PubMed ID: 29030863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression Analysis of Long Non-coding RNAs in the Blood of Multiple Sclerosis Patients.
    Eftekharian MM; Ghafouri-Fard S; Soudyab M; Omrani MD; Rahimi M; Sayad A; Komaki A; Mazdeh M; Taheri M
    J Mol Neurosci; 2017 Dec; 63(3-4):333-341. PubMed ID: 28967047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis.
    Santoro M; Nociti V; Lucchini M; De Fino C; Losavio FA; Mirabella M
    J Mol Neurosci; 2016 May; 59(1):18-23. PubMed ID: 27034068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analysis of OIP5-AS1/HUR1 to discover new potential biomarkers and therapeutic targets in multiple sclerosis.
    Gharesouran J; Taheri M; Sayad A; Mazdeh M; Omrani MD
    J Cell Physiol; 2019 Aug; 234(10):17351-17360. PubMed ID: 30815864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances of long noncoding RNAs involved in the development of multiple sclerosis.
    Li QW; Lei W; Chen C; Guo W
    Chin J Nat Med; 2020 Jan; 18(1):36-46. PubMed ID: 31955822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Study of ANRIL Genetic Variants and Multiple Sclerosis.
    Rezazadeh M; Gharesouran J; Moradi M; Noroozi R; Omrani MD; Taheri M; Ghafouri-Fard S
    J Mol Neurosci; 2018 May; 65(1):54-59. PubMed ID: 29713948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients.
    Santoro M; Nociti V; Lucchini M; Loiodice M; Centofanti F; Botta A; Losavio FA; De Fino C; Mirabella M
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3267-3273. PubMed ID: 32271444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do we know about the role of lncRNAs in multiple sclerosis?
    Nociti V; Santoro M
    Neural Regen Res; 2021 Sep; 16(9):1715-1722. PubMed ID: 33510060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNAs associated with multiple sclerosis expressed in the Th1 cell lineage.
    Hosseini A; Teimuri S; Ehsani M; Rasa SMM; Etemadifar M; Nasr Esfahani MH; Megraw TL; Ghaedi K
    J Cell Physiol; 2019 Dec; 234(12):22153-22162. PubMed ID: 31066039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes.
    Luo Z; Li Y; Liu X; Luo M; Xu L; Luo Y; Xiao B; Yang H
    BMC Med Genomics; 2015 Mar; 8():13. PubMed ID: 25889429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Long Non-Coding RNAs in Neurodegenerative Diseases: Novel Mechanisms of Pathogenesis.
    Riva P; Ratti A; Venturin M
    Curr Alzheimer Res; 2016; 13(11):1219-1231. PubMed ID: 27338628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression Profile of Long Noncoding RNAs in Peripheral Blood Mononuclear Cells from Multiple Sclerosis Patients.
    Zhang F; Gao C; Ma XF; Peng XL; Zhang RX; Kong DX; Simard AR; Hao JW
    CNS Neurosci Ther; 2016 Apr; 22(4):298-305. PubMed ID: 26842313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.